A Study Evaluating the Clinical Efficacy of Treatment based on Chinese Medicine Guideline in Patients With Myasthenia Gravis

The Affiliated Hospital of Changchun University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1.Age is not limited, gender is not limited;
•2.Clinical MG manifestations, and or neostigmine test positive, low frequency repeated electrical stimulation positive, serum AChR, Musk, LRP4, Titin, RyR and other antibodies are positive, clinical diagnosis of myasthenia gravis can be diagnosed;
•3.Patients with myasthenia gravis classified as type I, type II (type IIa, type IIb), III (type IIIa, type IIIb) and IV (type IVa, IVb) in clinical MGFA;
•4.Agree to participate in this study and sign an informed consent form.

•1.Patients with severe medical diseases: severe arrhythmia, severe lung disease, ALT/AST> 2 times the normal value, Cr> 2 times the normal value;
•2.Patients with malignant tumors (excluding thymoma), history of HIV infection, or severe immunodeficiency;
•3.Female patients who are pregnant, breastfeeding or breastfeeding;
•4.History of mental illness;
•5.Tuberculosis patients with tuberculin test or T-SPOT test positive.

发起方

The Affiliated Hospital of Changchun University of Traditional Chinese Medicine